COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,965 Articles (22,604 medRxiv, 8,361 bioRxiv)

Most recent first Previous |  Page 435: Articles 4341-4350  | Next

In vitro comparison of SARS-CoV-2 variants
Phadke, K. S., Higdon, N. B. A., Bellaire, B. H.
10.1101/2023.03.11.532212 — Posted: 2023-03-13
Resolving the developmental mechanisms of coagulation abnormalities characteristic of SARS-CoV2 based on single-cell transcriptome analysis
Luo, X., Zhang, N., Liu, Y., Du, B., Wang, X., Zhao, T., Liu, B., Zhao, S., Qiu, J., Wang, G.
10.1101/2023.03.13.532347 — Posted: 2023-03-13
Monoclonal antibodies against human coronavirus NL63 spike
Conlan, M., Tan, H.-X., Esterbauer, R., Kelly, A., Kent, S. J., Wheatley, A. K., Lee, W. S.
10.1101/2023.03.12.532265 — Posted: 2023-03-13
Correlating physicochemical and biological properties to define critical quality attributes of a recombinant AAV vaccine candidate
Kumar, P., Wang, M., Kumru, O. S., Hickey, J., Sanmiguel, J., Zabaleta, N., Vandenberghe, L. H., Joshi, S. B., Volkin, D. B.
10.1101/2023.03.10.532114 — Posted: 2023-03-13
Evolutionary changes in the number of dissociable amino acids on spike proteins and nucleoproteins of SARS-CoV-2 variants
Bozic, A., Podgornik, R.
10.1101/2023.03.12.532219 — Posted: 2023-03-13
Urine proteomic characterization of active and recovered COVID-19 patients
Sun, J., Wei, J., Yu, H., Sun, H., Liu, X., Zhang, Y., Shao, C., Sun, W., Gao, Y.
10.1101/2023.03.12.532269 — Posted: 2023-03-13
Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract
Moradi Marjaneh, M., Challenger, J. D., Salas, A., Gomez-Carballa, A., Sivananthan, A., Rivero-Calle, I., Barbeito-Castineiras, G., Foo, C. Y., Wu, Y., Liew, F., Jackson, H. R., Habgood-Coote, D., D'Souza, G., Nichols, S., Wright, V. J., Levin, M., Kaforou, M., Thwaites, R. S., Okell, L. C., Martinon-Torres, F., Cunnington, A. J., PERFORM Consortium, , GEN-COVID Study Group
10.1101/2023.03.09.23287028 — Posted: 2023-03-13
Anxiety, depression, and insomnia among nurses during the full liberalization of COVID-19: A multicenter cross-sectional analysis of the high-income region in China
Xiao, J., Liu, L., Yueming, Y., Wen, Y., Lv, X., Liang, L., Fan, Y., Chen, J., Chen, Y., Hu, H., Peng, W., Wang, H., Luo, W.
10.1101/2023.03.09.23286785 — Posted: 2023-03-13
Investigating the marginal and herd effects of COVID-19 vaccination for reducing case fatality rate: Evidence from the United States.
Li, T., Wang, Z., He, S., Chen, Y.
10.1101/2023.03.11.23287133 — Posted: 2023-03-12
No immunological interference or safety concerns when adjuvanted recombinant zoster vaccine is coadministered with a COVID-19 mRNA-1273 booster vaccine in adults aged 50 years and older: A randomized trial
Naficy, A., Kuxhausen, A., Pirrotta, P., Leav, B., Miller, J., Anteyi, K., Adams, M. S., Danier, J., Breuer, T., Mwakingwe-Omari, A.
10.1101/2023.03.10.23286967 — Posted: 2023-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).